BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kyu Shim M, Yang S, Sun IC, Kim K. Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery. Adv Drug Deliv Rev 2022;183:114177. [PMID: 35245568 DOI: 10.1016/j.addr.2022.114177] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Wang S, Li Y, Wang D, Zhang Y, Zhang H, Lei H, Liu X, Sun J, Sun B, He Z. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety. Acta Biomater 2023;157:417-27. [PMID: 36513247 DOI: 10.1016/j.actbio.2022.12.005] [Reference Citation Analysis]
2 He Z, Xiang W, Fan Q, Wang L, Chao J. A DNA origami nanostructure embedded with NQO1-activated prodrugs for precision drug delivery. Chem Commun (Camb) 2023;59:912-5. [PMID: 36594872 DOI: 10.1039/d2cc06367k] [Reference Citation Analysis]
3 Liu J, Jiang X, Feng X, Lee MJ, Li Y, Mao J, Weichselbaum RR, Lin W. A Three-in-One Nanoscale Coordination Polymer for Potent Chemo-Immunotherapy. Small Methods 2023;:e2201437. [PMID: 36638256 DOI: 10.1002/smtd.202201437] [Reference Citation Analysis]
4 Jafari-Matanagh S, Razavi SE, Ehghaghi Bonab MB, Omidian H, Omidi Y. Multi-dimensional modeling of nanoparticles transportation from capillary bed into the tumor microenvironment. Comput Biol Med 2023;152:106477. [PMID: 36571940 DOI: 10.1016/j.compbiomed.2022.106477] [Reference Citation Analysis]
5 Zhao C, Zhou B. Polyethyleneimine-Based Drug Delivery Systems for Cancer Theranostics. J Funct Biomater 2022;14. [PMID: 36662059 DOI: 10.3390/jfb14010012] [Reference Citation Analysis]
6 Shao Y, Xiang L, Zhang W, Chen Y. Responsive shape-shifting nanoarchitectonics and its application in tumor diagnosis and therapy. J Control Release 2022;352:600-18. [PMID: 36341936 DOI: 10.1016/j.jconrel.2022.10.046] [Reference Citation Analysis]
7 Yu H, Wu M, Chen S, Song M, Yue Y. Biomimetic nanoparticles for tumor immunotherapy. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.989881] [Reference Citation Analysis]
8 Wang F, Pu K, Li J. Activating Nanomedicines with Electromagnetic Energy for Deep‐Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy. Small Methods 2022. [DOI: 10.1002/smtd.202201083] [Reference Citation Analysis]
9 Liu Z, Xiang Y, Zheng Y, Kang X. Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology. Front Immunol 2022;13:1027124. [DOI: 10.3389/fimmu.2022.1027124] [Reference Citation Analysis]
10 Choi J, Lee IS, Lee JS, Jeon S, Yun WS, Yang S, Moon Y, Kim J, Kim J, Choy S, Jeong C, Shim MK, Kim TI, Kim K. Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light. Biomater Res 2022;26:56. [PMID: 36258234 DOI: 10.1186/s40824-022-00305-2] [Reference Citation Analysis]
11 Cho H, Shim MK, Moon Y, Song S, Kim J, Choi J, Kim J, Lee Y, Park JY, Kim Y, Ahn CH, Kim MR, Yoon HY, Kim K. Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy. Pharmaceutics 2022;14:2131. [PMID: 36297566 DOI: 10.3390/pharmaceutics14102131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shim MK, Yang S, Park J, Yoon JS, Kim J, Moon Y, Shim N, Jo M, Choi Y, Kim K. Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity. J Nanobiotechnology 2022;20:436. [PMID: 36195911 DOI: 10.1186/s12951-022-01644-x] [Reference Citation Analysis]
13 Yun WS, Shim MK, Lim S, Song S, Kim J, Yang S, Hwang HS, Kim MR, Yoon HY, Lim D, Sun I, Kim K. Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy. Nanomaterials 2022;12:3410. [DOI: 10.3390/nano12193410] [Reference Citation Analysis]
14 Mukherjee AG, Wanjari UR, Namachivayam A, Murali R, Prabakaran DS, Ganesan R, Renu K, Dey A, Vellingiri B, Ramanathan G, Doss C. GP, Gopalakrishnan AV. Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach. Vaccines 2022;10:1493. [DOI: 10.3390/vaccines10091493] [Reference Citation Analysis]
15 Zuo J, Gao X, Xiao J, Cheng Y. Carrier-free supramolecular nanomedicines assembled by small-molecule therapeutics for cancer treatment. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.107827] [Reference Citation Analysis]
16 Liu H, Liu D, Ji M, Xiao P, Qin Y, Zhao J, Wang N, Gou J, Yin T, He H, Chen G, Zhang Y, Tang X. Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids. Int J Pharm 2022;622:121900. [PMID: 35690305 DOI: 10.1016/j.ijpharm.2022.121900] [Reference Citation Analysis]
17 Chen Q, Li J, Shen P, Yuan H, Yin J, Ge W, Wang W, Chen G, Yang T, Xiao B, Miao Y, Lu Z, Wu P, Jiang K. Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star. Cell Biosci 2022;12:97. [PMID: 35729650 DOI: 10.1186/s13578-022-00833-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Jeon SI, Yang S, Shim MK, Kim K. Cathepsin B-responsive prodrugs for cancer-targeted therapy: Recent advances and progress for clinical translation. Nano Res . [DOI: 10.1007/s12274-022-4354-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shim MK, Song SK, Jeon SI, Hwang KY, Kim K. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy. Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2081683] [Reference Citation Analysis]
20 Zhang Y, Chang L, Bao H, Wu X, Liu H, Gou S, Zhang J, Ni J. Constructing New Acid-Activated Anticancer Peptide by Attaching a Desirable Anionic Binding Partner Peptide. J Drug Target 2022;:1-26. [PMID: 35502656 DOI: 10.1080/1061186X.2022.2070627] [Reference Citation Analysis]
21 Cho IK, Shim MK, Um W, Kim JH, Kim K. Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer. Molecules 2022;27:2529. [PMID: 35458727 DOI: 10.3390/molecules27082529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]